Cargando…

Cost per DALY averted in low, middle- and high-income countries: evidence from the global burden of disease study to estimate the cost-effectiveness thresholds

BACKGROUND: Determining the cost-effectiveness thresholds for healthcare interventions has been a severe challenge for policymakers, especially in low- and middle-income countries. This study aimed to estimate the cost per disability-adjusted life-year (DALY) averted for countries with different lev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Daroudi, Rajabali, Akbari Sari, Ali, Nahvijou, Azin, Faramarzi, Ahmad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7863358/ https://www.ncbi.nlm.nih.gov/pubmed/33541364 http://dx.doi.org/10.1186/s12962-021-00260-0

Ejemplares similares

Comparing the cost-per-QALYs gained and cost-per-DALYs averted literatures
por: Neumann, Peter J., et al.
Publicado: (2018)

Cost-Effectiveness of Different Cervical Screening Strategies in Islamic Republic of Iran: A Middle-Income Country with a Low Incidence Rate of Cervical Cancer
por: Nahvijou, Azin, et al.
Publicado: (2016)

A cost-effectiveness modeling study of treatment interventions for stage I to III esophageal squamous cell carcinoma
por: Daroudi, Rajabali, et al.
Publicado: (2022)

Use and Misuse of Cost-Effectiveness Analysis Thresholds in Low- and Middle-Income Countries: Trends in Cost-per-DALY Studies
por: Leech, Ashley A., et al.
Publicado: (2018)

A Systematic Review of Cost-Effectiveness Studies Reporting Cost-per-DALY Averted
por: Neumann, Peter J., et al.
Publicado: (2016)

The Economic Burden of Breast Cancer in Iran
por: DAROUDI, Rajabali, et al.
Publicado: (2015)

Adherence to the iDSI reference case among published cost-per-DALY averted studies
por: Emerson, Joanna, et al.
Publicado: (2019)

Direct Costs of Hypertension Treatment in Iran
por: Zamandi, Mahmoud, et al.
Publicado: (2023)

Economic burden of colorectal cancer in Iran in 2012
por: Vahdatimanesh, Zahra, et al.
Publicado: (2017)

Disability-Adjusted Life Years (DALY) for Cancers in Iran, 1990 to 2016: Review of Findings from the Global Burden of Disease Study
por: Nahvijou, Azin
Publicado: (2021)

Burden of smoking on disease-specific mortality, DALYs, costs: the case of a high-income European country
por: Farcher, Renato, et al.
Publicado: (2023)

Extent, nature and hospital costs of fireworks-related injuries during the Wednesday Eve Festival in Iran
por: Alinia, Siros, et al.
Publicado: (2013)

Determination of a cost-effectiveness threshold for cancer interventions in Iran
por: Safari, Hossein, et al.
Publicado: (2022)

Direct costs of common osteoporotic fractures (Hip, Vertebral and Forearm) in Iran
por: Rajabi, Marziyeh, et al.
Publicado: (2021)

Mothers’ preferences and willingness-to-pay for human papillomavirus vaccines in Iran: A discrete choice experiment study
por: Sargazi, Nasrin, et al.
Publicado: (2021)

Cost per Event Averted in Cancer Trials in the Adjuvant Setting From 2018 to 2022
por: Mousavi, Idine, et al.
Publicado: (2022)

Estimating deaths averted and cost per life saved by scaling up mRNA COVID-19 vaccination in low-income and lower-middle-income countries in the COVID-19 Omicron variant era: a modelling study
por: Savinkina, Alexandra, et al.
Publicado: (2022)

The Burden of Cardiovascular Disease Attributable to Modifiable Risk Factors and Cost-effectiveness Analysis of IraPEN Program in the General Population of Iran
por: Mokhtari, Mehdi, et al.
Publicado: (2022)

The burden of COVID-19 in French Guiana: Vaccine-averted deaths, hospitalizations and costs
por: Nacher, Mathieu, et al.
Publicado: (2023)

Cost Burden of Rigid Internal Fixation in Craniomaxillofacial Trauma Care in Low‐ and Middle‐Income Countries
por: Shaye, David A., et al.
Publicado: (2023)

Time to include burden of surgical injuries after disasters in the Global Surgery agenda? An assessment of DALYs and averted burden by surgery after the 2008 Wenchuan earthquake
por: Rodriguez-Llanes, Jose Manuel, et al.
Publicado: (2018)

Public Preferences and Willingness to Pay for a COVID-19 Vaccine in Iran: A Discrete Choice Experiment
por: Darrudi, Alireza, et al.
Publicado: (2022)

Public preferences regarding the priority setting criteria of health interventions for budget allocation: results of a survey of Iranian adults
por: Darvishi, Ali, et al.
Publicado: (2022)

Surgical site infection and costs in low- and middle-income countries: A systematic review of the economic burden
por: Monahan, Mark, et al.
Publicado: (2020)

Cost-utility analysis of Cryoballoon ablation versus Radiofrequency ablation in the treatment of paroxysmal atrial fibrillation in Iran
por: Darvishi, Ali, et al.
Publicado: (2022)

Cost-effectiveness of measles and rubella elimination in low-income and middle-income countries
por: Levin, Ann, et al.
Publicado: (2023)

Cost and cost-effectiveness of childhood cancer treatment in low-income and middle-income countries: a systematic review
por: Fung, Alastair, et al.
Publicado: (2019)

Dalí --- Dalí --- Dalí
por: Dalí, Salvador, 1904-1989
Publicado: (1974)

A cost-effectiveness analysis of risk-based intervention for prevention of cardiovascular diseases in IraPEN program: A modeling study
por: Jamshidi, Amirparviz, et al.
Publicado: (2023)

Epidemiology and Hospitalization Cost of Bladder Cancer in Kerman Province, Southeastern Iran
por: RASHIDIAN, Hamideh, et al.
Publicado: (2018)

Direct and indirect medical costs of bladder cancer in Iran
por: Raadabadi, Mehdi, et al.
Publicado: (2023)

The cost-effectiveness of hypertension management in low-income and middle-income countries: a review
por: Kostova, Deliana, et al.
Publicado: (2020)

The Use of Cost-Effectiveness Thresholds for Evaluating Health Interventions in Low- and Middle-Income Countries From 2015 to 2020: A Review
por: Kazibwe, Joseph, et al.
Publicado: (2022)

Cost-utility analysis of Palbociclib + letrozole and ribociclib + letrozole versus Letrozole monotherapy in the first-line treatment of metastatic breast cancer in Iran using partitioned survival model
por: Darvishi, Ali, et al.
Publicado: (2023)

Economic Costs of Childhood Lead Exposure in Low- and Middle-Income Countries
por: Attina, Teresa M., et al.
Publicado: (2013)

The cost of dialysis in low and middle-income countries: a systematic review
por: Mushi, Lawrencia, et al.
Publicado: (2015)

Life and health satisfaction in the adult population of Iran
por: Daroudi, Rajabali, et al.
Publicado: (2016)

Correction to: Health-related quality of life measured using the EQ-5D-5 L: population norms for the capital of Iran
por: Emrani, Zahra, et al.
Publicado: (2020)

Health-related quality of life measured using the EQ-5D–5 L: population norms for the capital of Iran
por: Emrani, Zahra, et al.
Publicado: (2020)

The cost and cost-effectiveness of novel tuberculosis vaccines in low- and middle-income countries: A modeling study
por: Portnoy, Allison, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1vmifgt86n5ftohneq7n2edvpd